Daniel E Soffer
Overview
Explore the profile of Daniel E Soffer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hegele R, Ahmad Z, Ashraf A, Baldassarra A, Brown A, Chait A, et al.
J Clin Lipidol
. 2024 Nov;
19(1):83-94.
PMID: 39537503
Background: Familial chylomicronemia syndrome (FCS) is an ultrarare inherited disorder. Genetic testing is not always feasible or conclusive. European clinicians developed a "FCS score" to differentiate between FCS and multifactorial...
2.
Koschinsky M, Soffer D, Boffa M
J Clin Lipidol
. 2024 Sep;
18(6):e886-e892.
PMID: 39299825
This is an exciting time in the lipoprotein(a) [Lp(a)] field. Attention to this important lipoprotein and potent cardiovascular risk marker is transitioning from the purview of the specialist to that...
3.
DSouza J, Soffer D, Bajaj A
J Clin Lipidol
. 2024 Sep;
18(5):e873-e876.
PMID: 39289122
Guidelines recommend checking lipoprotein(a) [Lp(a)] levels in patients at high-risk for cardiovascular disease, with more recent recommendations advocating for universal screening in all adults. A brief electronic survey was distributed...
4.
Soffer D, Marston N, Maki K, Jacobson T, Bittner V, Pena J, et al.
J Clin Lipidol
. 2024 Sep;
18(5):e647-e663.
PMID: 39256087
This National Lipid Association (NLA) Expert Clinical Consensus provides an overview of the physiologic and clinical considerations regarding the role of apolipoprotein B (apoB) measurement to guide clinical care based...
5.
Safarova M, Bimal T, Soffer D, Hirsh B, Shapiro M, Mintz G, et al.
Am J Prev Cardiol
. 2024 Jul;
19:100701.
PMID: 39070027
There is a direct relationship between the duration and level of exposure to low density lipoprotein cholesterol (LDL-C) levels over one's lifespan and cardiovascular events. Early treatment to lower elevated...
6.
Song W, Soffer D, Gelfand J
Dermatol Clin
. 2024 May;
42(3):417-428.
PMID: 38796273
National guidelines define psoriasis as a risk enhancer for cardiovascular disease and recommend increased monitoring and more intense management of cardiovascular risk factors in these patients, who face an increased...
7.
Filtz A, Parihar S, Greenberg G, Park C, Scotti A, Lorenzatti D, et al.
Am J Prev Cardiol
. 2024 Apr;
18:100648.
PMID: 38584606
Triglycerides play a crucial role in the efficient storage of energy in the body. Mild and moderate hypertriglyceridemia (HTG) is a heterogeneous disorder with significant association with atherosclerotic cardiovascular disease...
8.
Koschinsky M, Bajaj A, Boffa M, Dixon D, Ferdinand K, Gidding S, et al.
J Clin Lipidol
. 2024 Apr;
18(3):e308-e319.
PMID: 38565461
Since the 2019 National Lipid Association (NLA) Scientific Statement on Use of Lipoprotein(a) in Clinical Practice was issued, accumulating epidemiological data have clarified the relationship between lipoprotein(a) [Lp(a)] level and...
9.
Sheth S, Lee P, Bajaj A, Cuchel M, Hajj J, Soffer D, et al.
Circ Cardiovasc Qual Outcomes
. 2021 Jun;
14(6):e007641.
PMID: 34107738
No abstract available.
10.
Mszar R, Mahajan S, Valero-Elizondo J, Grandhi G, Caraballo C, Gopal D, et al.
Eur J Prev Cardiol
. 2021 Feb;
29(1):e11-e13.
PMID: 33624106
No abstract available.